Compass: Beating The Industry At Every Turn
Zelman & Assoc Downgrades Compass (COMP)
Zelman & Assoc Downgrades Compass to Neutral, Announces $13.5 Price Target
Goldman Sachs Maintains Neutral on Compass, Raises Price Target to $12
Oppenheimer Maintains Outperform on Compass, Raises Price Target to $18
Compass, Inc. 2026 Q2 - Results - Earnings Call Presentation
Wells Fargo Maintains Equal-Weight on Compass, Raises Price Target to $13
Barclays Maintains Overweight on Compass, Raises Price Target to $16
Compass (NYSE:COMP) Rallies on Record Q2 Revenue and Early Anywhere Cost Synergies
Compass, Inc. (COMP) Q2 2026 Earnings Call Transcript
Compass Sees Q3 Sales $3.850B-$4.050B vs $3.745B Est
Compass Q2 EPS $0.11 Misses $0.12 Estimate, Sales $4.306B Beat $4.081B Estimate
UBS Maintains Buy on Compass, Raises Price Target to $17
Barclays Maintains Overweight on Compass, Raises Price Target to $15
Compass: Profit Can Multiply When Housing Market Recovers
Compass is keeping homes off the open market. Critics say it's making the housing crisis worse.
Compass’s Q1 Earnings Call: Our Top 5 Analyst Questions
Guaranteed Rate Affinity’s Bob Bachman Launches The Bachman Team
Guaranteed Rate Affinity’s Fe David Launches The David Team to Better Serve Clients in California
Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.